CanaQuest Medical Corp. CANQF
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.0001 Day range 0.0001
0.0001 52-week range 0.0001
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 2.12K
- Vol
- 361.55K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0001
- High
- 0.0001
2Y chart
Signals (35)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 31, 2025 | 1 year ago |
| SMA: Bearish | Oct 13, 2025 | 1 year ago |
| RSI: Oversold | Oct 13, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 10, 2025 | 1 year ago |
| SMA: Bullish | Aug 29, 2025 | 1 year ago |
| SMA: Bearish | Aug 18, 2025 | 1 year ago |
| SMA: Bullish | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 12, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 31, 2025 | 1 year ago |
| SMA: Bearish | Jul 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 8, 2025 | 1 year ago |
| RSI: Oversold | Jul 8, 2025 | 1 year ago |
| SMA: Bullish | Jun 16, 2025 | 1 year ago |
| RSI: Overbought | Jun 16, 2025 | 1 year ago |
| MACD: Buy Signal | May 19, 2025 | 1 year ago |
| MACD: Sell Signal | May 1, 2025 | 1 year ago |
| RSI: Oversold | May 1, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Mar 19, 2025 | 1 year ago |
| SMA: Bullish | Mar 18, 2025 | 1 year ago |
| RSI: Oversold | Mar 13, 2025 | 1 year ago |
| SMA: Bearish | Mar 11, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 11, 2025 | 1 year ago |
| SMA: Bullish | Feb 18, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 14, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 5, 2025 | 1 year ago |
| SMA: Bearish | Feb 4, 2025 | 1 year ago |
| SMA: Bullish | Jan 31, 2025 | 1 year ago |
| SMA: Bearish | Jan 30, 2025 | 1 year ago |
| SMA: Bullish | Jan 22, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 15, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 31, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 26, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 24, 2024 | 1 year ago |
News
- CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program
- CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health
- CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications
Your note
Sign in to keep a note on CANQF — it syncs with the Stock Master app.